20 results
6-K
EX-99.1
SPRC
SciSparc Ltd
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
Exhibit 99.1
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
The Soroka University Ethics … to treat disorders of the central nervous system, today announced that it has received approval from the Ethics Committee of The Soroka University
6-K
EX-99.1
SPRC
SciSparc Ltd
26 May 22
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
8:33am
Exhibit 99.1
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
Ethics Committee approval received … of the central nervous system, today announced it received Ethics Committee approvals from Hannover Medical School in Hannover, Germany, and the Tel Aviv
6-K
SPRC
SciSparc Ltd
26 May 22
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
8:33am
. (the “Company”) issued a press release titled “SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome”. A copy …
Exhibit No.
Press release titled: “SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome”.
SIGNATURES
Pursuant
6-K
SPRC
SciSparc Ltd
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
”) issued a press release titled “SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder”. A copy … by SciSparc Ltd. on June 23, 2022 titled “SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
6-K
EX-99.1
SPRC
SciSparc Ltd
29 Jun 22
SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
8:36am
for Tourette Syndrome (“TS”).
The Company recently announced that it has received ethics committee approvals from Hannover Medical School in Hannover, Germany
6-K
EX-99.1
i1jq f5hd
11 Aug 22
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:42am
6-K
EX-99.1
gh9qwjuw5r0cvedocqsq
17 Jul 23
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
8:00am
20-F
mzolf7ppo53lu9qp9u
1 May 17
Annual report (foreign)
12:00am
F-1
4ln pvhbq3
27 Feb 24
Registration statement (foreign)
4:15pm
F-1/A
z3bw3w19v5n6g 7yqt79
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
mdze43q
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
3gn 0253x5m
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1/A
2pj6wlrq8t18dptjafx1
26 Mar 20
Registration statement (foreign) (amended)
12:00am
424B4
ai70g5 y8za
2 Apr 20
Prospectus supplement with pricing info
5:28pm
- Prev
- 1
- Next